Menu
GeneBe

SUV39H2

SUV39H2 histone lysine methyltransferase, the group of Lysine methyltransferases|SET domain containing

Basic information

Region (hg38): 10:14878819-14904315

Links

ENSG00000152455NCBI:79723OMIM:606503HGNC:17287Uniprot:Q9H5I1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SUV39H2 gene.

  • Inborn genetic diseases (6 variants)
  • not provided (3 variants)
  • not specified (2 variants)
  • Histiocytic medullary reticulosis (1 variants)
  • Severe combined immunodeficiency due to DCLRE1C deficiency (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUV39H2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
5
clinvar
1
clinvar
6
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
2
clinvar
2
clinvar
4
Total 0 0 5 3 2

Variants in SUV39H2

This is a list of pathogenic ClinVar variants found in the SUV39H2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-14881511-C-A not specified Uncertain significance (Feb 23, 2023)2488990
10-14897157-G-T not specified Uncertain significance (Jul 25, 2023)2613711
10-14897194-A-C not specified Uncertain significance (Aug 23, 2021)2246667
10-14897282-A-C not specified Uncertain significance (Dec 05, 2022)2332837
10-14897449-C-T not specified Likely benign (Jul 21, 2021)2403926
10-14899056-T-G not specified Benign (Jan 24, 2024)2688318
10-14899187-G-A Likely benign (Oct 01, 2023)1694558
10-14899206-G-C Likely benign (Nov 01, 2023)2570766
10-14899234-C-T Severe combined immunodeficiency due to DCLRE1C deficiency • Histiocytic medullary reticulosis • not specified Benign (Jan 24, 2024)1255460
10-14899244-C-G SUV39H2-related disorder Likely benign (Jun 05, 2019)3043912
10-14899283-G-A DCLRE1C-related disorder Likely benign (Jun 20, 2019)3042857
10-14899533-G-C Benign (Mar 29, 2018)711031
10-14899588-A-G not specified Uncertain significance (Sep 12, 2023)2622610
10-14902438-C-G not specified Uncertain significance (Oct 05, 2023)3172315

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SUV39H2protein_codingprotein_codingENST00000354919 625496
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9290.0708125729031257320.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.28762100.3620.00001022686
Missense in Polyphen1491.9110.152321219
Synonymous0.3597073.90.9470.00000379746
Loss of Function3.72321.70.1380.00000133253

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 using monomethylated H3 'Lys- 9' as substrate. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as cell cycle regulation, transcriptional repression and regulation of telomere length. May participate in regulation of higher-order chromatin organization during spermatogenesis. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation. {ECO:0000269|PubMed:14765126}.;
Pathway
Lysine degradation - Homo sapiens (human);Histone Modifications;PKMTs methylate histone lysines;Chromatin modifying enzymes;Lysine metabolism;Chromatin organization (Consensus)

Recessive Scores

pRec
0.0916

Intolerance Scores

loftool
0.103
rvis_EVS
-0.3
rvis_percentile_EVS
32.62

Haploinsufficiency Scores

pHI
0.301
hipred
Y
hipred_score
0.633
ghis
0.701

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Suv39h2
Phenotype
reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; embryo phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;chromatin assembly or disassembly;chromatin remodeling;cell cycle;cell differentiation;histone H3-K9 dimethylation;histone H3-K9 trimethylation;negative regulation of circadian rhythm;negative regulation of transcription, DNA-templated;rhythmic process;cellular response to hypoxia
Cellular component
chromosome, centromeric region;chromatin;nucleoplasm
Molecular function
transcription regulatory region sequence-specific DNA binding;protein binding;zinc ion binding;histone-lysine N-methyltransferase activity;histone methyltransferase activity (H3-K9 specific);S-adenosyl-L-methionine binding